期刊文献+

三阴乳腺癌相关性因素研究进展 被引量:3

Research development of triple negative breast cancer correlatile factors
下载PDF
导出
摘要 三阴乳腺癌(triple-negative breast cancer,TNBC)即雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2(HER-2)均为阴性的乳腺癌。是一种特殊类型的乳腺癌,具有独特的生物学行为和临床特征,预后差。对三阴乳腺癌相关性因素的深入研究,将有助于该病的预防、早期诊断、判断疾病的进展和指导治疗。 Triple - negative breast cancer(TNBC) is defined as lack of estrogen receptor(ER) , progesterone receptor ( PR ) and human epidermal growth factor receptor - 2 ( HER - 2) expression, it is a subtype of tumor with distinct clin- ical and pathologic features and poor prognosis. A deeper insight into the correlative factors of TNBC may lead to con- tribute to the prevention of disease,early diagnosis,judge the progress of the disease and guiding treatment.
出处 《现代肿瘤医学》 CAS 2014年第3期707-709,共3页 Journal of Modern Oncology
基金 云南省卫生厅内设机构资助项目(编号:2012us0048)
关键词 三阴乳腺癌 相关因素 BLBC 叶酸 MTHFR BRCA1EGFR P53 KI-67 triple - negative breast cancer correlative factors BLBC folate MTHFR BRCA1 EGFR p53 Ki - 67
  • 相关文献

参考文献3

二级参考文献65

  • 1杜长征,李惠平,马力文,付卫,王墨培,贾廷珍,赵红梅,侯宽永.中国乳腺癌患者p53表达临床生物学意义的Meta分析[J].中国癌症杂志,2005,15(6):514-517. 被引量:23
  • 2Sorlie T,Perou CM,Tibshirani R,et al.Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications[J].Proc Natl Acad Sci U S A,2001,98(19):10869-10874.
  • 3Norbeng T,Klaar S,Karl G,et al.Increased p53 mutation frequency during tumor progression results from a breast cancer cohort[J].Cancer Res,2001,61(22):8317-8321.
  • 4Dookeran KA,Dignam JJ,Ferrer K,et al.p53 as a marker of prognosis in African-American women with breast cancer[J].Ann Surg Oncol,2010,17(5):1398-1405.
  • 5Chae BJ,Bae JS,Lee A,et al.p53 as a specific prognostic factor in triple-negative breast cancer[J].Jpn J Clin Oncol,2009,39(4):217-224.
  • 6Rakha EA,El-Sayed ME,Green AR,et al.Prognostic markers in triple-negative breast cancer[J].Cancer,2007,109(1):25-32.
  • 7Geisler S,Lonning PE,Aas T,et a1.Influence of TP53 gene alterations and cerbB2 expression on the response to treatment with doxorubicin in locally advanced breast cancer[J].Cancer Res,2001,61(6):2505-2512.
  • 8Malamou-Mitsi V,Gogas H,Dafni U,et al.Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy[J].Ann Oncol,2006,17(10):1504-1511.
  • 9Phil R,Ian S,Zanra M,et al.The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer[J].Int J Cancer,2006,120(6):1311-1317.
  • 10Sidoni A,Cavaliere A,Bellezza G,et al.Coexpression of HER-2/neu and p53 in breast cancer inentifies a subset with an aggressive biopathological profile[J].Tumori,2006,92(5):412-415.

共引文献187

同被引文献30

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部